Managing patients on immunosuppressant therapy
We are aware that members of BISOM are receiving enquiries relating to patients taking immunosuppressant therapy and the risk of COVID-19 (coronavirus) infection. BISOM advises members to refer to the guidance provided by our affiliated medical specialties, this includes advice on which patients should practice shielding:
The Academy of Medical Royal Colleges (AoMRC) has released documentation from NHS England to assist in notifying patients at high risk who should practice shielding. Whilst the 4 UK nations have agreed this approach, the logistics and letters for the devolved administrations have not been finalised and further information will follow on these.
BISOM will continue to monitor this evolving situation and issue further advice if necessary.